CNS >

Myxopapillary Ependymoma

Definition

Well delimited glial tumor with ependymal features, and a prominent myxoid-papillary appearance, usually localized at he filum terminale or conus medullaris.

Clinical Features

Pathogenesis

  • Probably originate from:
    • ependymal rests representing remnants of extradural filum terminale, or
    • coccygeal medullary vestige
      • a derivative of the caudal neural tube persisting beneath skin of the postanal pit as an ependyma-lined cleft
  • Rests:
    • can exhibit myxopapillary features
    • should not be construed as neoplastic by sole virtue of this growth pattern9

Gross Pathology

  • Surgical exploration:
    • typically:
      • highly vascularized
      • ovoid or sausage-shaped mass
    • may be invested by fibrous pseudocapsule derived from stroma of filum
    • advanced examples may:
      • envelop cauda equina
      • erode neighboring bony structures
      • infiltrate paraspinal soft tissues
  • Gelatinous appearance on sectioning
  • Many show hemorrhagic discoloration.

Histopathology

  • Usually instantly recognizable
  • Cuboidal tumor cells:
    • drape about basophilic mucinous material that collars stromal blood vessels and collects in microcystic spaces (Fig. 1
      Myxopapillary ependymoma. Note the manner in which mucinous material separates draping tumor cells from a hyalinized vascular core and accumulates in rounded microcysts.

      Fig. 1: Myxopapillary ependymoma. Note the manner in which mucinous material separates draping tumor cells from a hyalinized vascular core and accumulates in rounded microcysts.

      )
  • Often spindly elements:
    • may engage in formation of gliovascular pseudorosettes
  • ‘Giant cell’ ependymoma arising in filum terminale may contain conventional myxopapillary components10
  • Sometimes:
    • eosinophilic spherules (‘balloons’):
      • possibly representing amalgamated collagen fibrils
    • myxoid matrix components
    • basal lamina materials1
  • Common degenerative alterations include:
    • vascular sclerosis
    • hemorrhage
    • hemosiderin deposition
  • Longstanding cases:
    • sometimes:
      • extensive fibrous tissue overgrowth
      • virtual obliteration of neoplastic cellular elements
  • Ultrastructurally:
    • similar to other ependymomas, but:
      • less conspicuous cilia and microvilli
      • consistently elaborate basal lamina material that may invest cells as continuous basement membrane
      • may contain unique and specific ultrastructural marker of microtubules aggregated within cisternae of rough endoplasmic reticulum11

Special Stains and Immunohistochemistry

  • Characteristic immunophenotype:
    • coexpression of:
      • vimentin
      • S-100 protein
      • GFAP
    • do not elaborate:
      • EMA
      • chromogranin
      • carcinoembryonic antigen (CEA)
    • exhibit little if any labeling for:
      • CAM 5.2
      • CK7
      • CK20

Diagnosis

Variants

  • If particularly myxomatous may assume chordoma-like appearance
  • If dominated by spindle cell elements may be mistaken for schwannomas of spinal nerve root origin

Other Investigations

  • Neuroimaging:
    • usually sharply delimited contrast-enhancing mass

Differential Diagnosis

Select up to 2 differential diagnoses to compare with Myxopapillary Ependymoma

(View full diagnosis)
(View full diagnosis)
(View full diagnosis)
(View full diagnosis)


Mucinous Carcinoma, Myxochordoid Meningioma, Paraganglioma of Cauda Equina Region1,12,13

Prognosis

References

1 Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–893.

2 Wiestler OD, Schiffer D, Coons SW, Prayson RA, Rosenblum MK. Ependymal tumors. Kleihues P, Cavenee WK editor. World Health Organization classification of tumours. Pathology and genetics-tumours of the nervous system. Lyon: IARC Press; 2000.

3 Maruyama R, Koga K, Nakahara T, Kishida K, Nabeshima K. Cerebral myxopapillary ependymoma. Hum Pathol. 1992;23:960–962.

4 Helwig EB, Stern JB. Subcutaneous sacrococcygeal myxopapillary ependymoma. A clinicopathologic study of 32 cases. Am J Clin Pathol. 1984;81:156–161.

5 Kline MJ, Kays DW, Rojiani AM. Extradural myxopapillary ependymoma. Report of two cases and review of the literature. Pediatr Pathol Lab Med. 1996;16:813–822.

6 Miralbell R, Louis DN, O'Keeffe D, Rosenberg AE, Suit HD. Metastatic ependymoma of the sacrum. Cancer. 1990;65:2353–2355.

7 Davis C, Barnard RO. Malignant behavior of myxopapillary ependymoma. Report of three cases. J Neurosurg. 1985;62:925–929.

8 al Moutaery K, Aabed MY, Ojeda VJ. Cerebral and spinal cord myxopapillary ependymomas. A case report. Pathology. 1996;28:373–376.

9 Pulitzer DR, Martin PC, Collins PC, Ralph DR. Subcutaneous sacrococcygeal (“myxopapillary”) ependymal rests. Am J Surg Pathol. 1988;12:672–677.

10 Zec N, De Girolami U, Schofield DE, Scott RM, Anthony DC. Giant cell ependymoma of the filum terminale. A report of two cases. Am J Surg Pathol. 1996;20:1091–1101.

11 Ho KL. Microtubular aggregates within rough endoplasmic reticulum in myxopapillary ependymoma of the filum terminale. Arch Pathol Lab Med. 1990;114:956–960.

12 Coffin CM, Swanson PE, Wick MR, Dehner LP. An immunohistochemical comparison of chordoma with renal cell carcinoma, colorectal adenocarcinoma, and myxopapillary ependymoma. A potential diagnostic dilemma in the diminutive biopsy. Mod Pathol. 1993;6:531–538.

13 Vege KD, Giannini C, Scheithauer BW. The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol. 2000;8:25–31.

Last updated: 11 Feb 2006

Myxopapillary Ependymoma

Back to top